Skip to search formSkip to main contentSkip to account menu

RotaTeq

National Institutes of Health

Related topics

Related topics

6 relations

Broader (5)

Human-Bovine Reassortant Rotavirus Strain G3 VaccineHuman-Bovine Reassortant Rotavirus Strain G4 VaccineRotavirus VaccinesVaccines, Attenuated
RotaTeq Oral Product

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Shedding of oral pentavalent bovine-human reassortant rotavirus vaccine indicates high uptake rate of vaccine and prominence of G-type G1.
2017
2017
Phylogenetic comparison of the VP7, VP4, VP6, and NSP4 genes of rotaviruses isolated from children in Nizhny Novgorod, Russia, 2015–2016, with cogent genes of the Rotarix and RotaTeq vaccine strains
Group A rotaviruses (RVA) are one of the leading causes of gastroenteritis in young children worldwide. The introduction of… 
2017
2017
Immunization of Mice by Rotavirus NSP4-VP6 Fusion Protein Elicited Stronger Responses Compared to VP6 Alone.
Abstract Due to the limitations and safety issues of the two currently approved live attenuated rotavirus (RV) vaccines “RotaTeq… 
2016
2016
One-step multiplex real-time RT-PCR assay for detecting and genotyping wild-type group A rotavirus strains and vaccine strains (Rotarix® and RotaTeq®) in stool samples
Background. Group A rotavirus (RVA) infection is the major cause of acute gastroenteritis (AGE) in young children worldwide… 
2016
2016
Differentiation of RotaTeq® vaccine strains from wild-type strains using NSP3 gene in reverse transcription polymerase chain reaction assay.
Review
2015
Review
2015
Detection of Vaccine-derived Rotavirus Strains in Nonimmunocompromised Children up to 3–6 Months After RotaTeq® Vaccination
We conducted a survey on the presence of RotaTeq vaccine viruses in infants hospitalized with respiratory infection, and detected… 
Review
2015
Review
2015
Value of Post-Licensure Data on Benefits and Risks of Vaccination to Inform Vaccine Policy: The Example of Rotavirus Vaccines.
2012
2012
Vaccination with 3-dose paediatric rotavirus vaccine (RotaTeq®): impact on the timeliness of uptake of the primary course of DTPa vaccine.
2010
2010
RotaTeq: Progress toward developing world access.
Phase III studies of an oral, live, pentavalent, human-bovine reassortant rotavirus vaccine (RotaTeq; Merck) in developed… 
Review
2008
Review
2008
RotaTeq™: a three-dose oral pentavalent reassortant rotavirus vaccine
Rotavirus (RV) is a leading cause of diarrhea worldwide, and will infect every child by their 5th birthday. The 3-dose oral… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)